کاستینگ (مهار کردن گنادوتروپینها) به منظور پیشگیری از سندرم تحریک بیش از حد تخمدان
Información
- DOI:
- https://doi.org/10.1002/14651858.CD002811.pub4Copiar DOI
- Base de datos:
-
- Cochrane Database of Systematic Reviews
- Versión publicada:
-
- 23 mayo 2017see what's new
- Tipo:
-
- Intervention
- Etapa:
-
- Review
- Grupo Editorial Cochrane:
-
Grupo Cochrane de Ginecología y fertilidad
- Copyright:
-
- Copyright © 2017 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Cifras del artículo
Altmetric:
Citado por:
Autores
Contributions of authors
Arianna D'Angelo took the lead in writing the protocol and review, performed searches of databases and contacted journals for trials, performed independent data extraction and quality assessment of the included trials, and was responsible for statistical analysis and interpretation of the data.
Nazar Amso assisted in writing the protocol and the final manuscript of the review, was involved in selecting trials for the review, and performed independent data extraction and quality assessment of the included trials.
Dr Julie Brown assisted with the update of the review in 2010, with the data analysis, interpretation and writing.
Dr Rudaina Hassan assisted in the update of the review in 2016, with data analysis, interpretation and writing.
Sources of support
Internal sources
-
Department of Obstetrics & Gynaecology, University Hospital of Wales, UK.
External sources
-
None, Other.
Declarations of interest
ADA, NNA and RH have no conflicts of interest to declare
Acknowledgements
The authors wish to thank the Cochrane Gynaecology and Fertility Group editorial office staff for their advice and support through the review process.
We thank also Dr Julie Brown for her contributions to previous versions of this review.
Version history
| Published | Title | Stage | Authors | Version |
| 2017 May 23 | Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome | Review | Arianna D'Angelo, Nazar N Amso, Rudaina Hassan | |
| 2011 Jun 15 | Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome | Review | Arianna D'Angelo, Julie Brown, Nazar N Amso | |
| 2011 Feb 16 | Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome | Review | Arianna D'Angelo, Julie Brown, Nazar N Amso | |
| 2002 Jul 22 | Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome | Review | Arianna D'Angelo, Nazar N Amso, Julie Brown | |
Differences between protocol and review
The number of embryos transferred was removed as an outcome in the 2010 update. It was not a measure of the treatment effect as the number of embryos transferred is subject to external regulation.
The number of patients admitted to hospital was removed as an outcome in the 2017 update, as this is not a measure of the treatment effect, since management protocols for OHSS may vary in different centres. The number of days to next menstrual period was removed as an outcome in the 2017 update, as this is not a measure of the severity of OHSS. The miscarriage rate was added as an outcome in 2017, as it is a relevant clinical outcome. Multiple pregnancy rate and miscarriage rate were analyzed both per woman randomised and per pregnancy in this update, to explore whether our findings were sensitive to the choice of analysis.
We amended the inclusion criteria for participants, as it was previously unclear whether only women with PCOS were eligible: we have clarified that women with PCOS are eligible, but the review was not restricted to women with PCOS
